Work

Preliminary Safety and Efficacy Results from a Phase 2 Study of Acalabrutinib, Venetoclax and Obinutuzumab in Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL)

Year: 2019

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2019-127506

Authors: Benjamin L. Lampson, Svitlana Tyekucheva, Jennifer L. Crombie, Austin I Kim, Reid W Merryman, Jessica Lowney, Josie Montegaard, Victoria Patterson, Caron A. Jacobson, Eric D Jacobsen, Ann S. LaCasce, Jon E. Arnason, Philippe Armand, David C. Fisher, Jennifer R. Brown, Matthew S. Davids

Institutions: Dana-Farber Cancer Institute, Beth Israel Deaconess Medical Center

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2987080466

Cites:

Cited by: 31

Related to: 10